Anturein
Anturein is a synthetic peptide originally developed as a potential therapeutic agent for treating inflammatory and autoimmune diseases. It is derived from the sequence of the human protein annexin A1, a protein involved in regulating inflammation and immune responses. The peptide was designed to mimic the anti-inflammatory properties of annexin A1 while avoiding potential side effects associated with full-length protein administration.
Research into anturein has primarily focused on its ability to modulate inflammation through interactions with specific
The compound was first described in scientific literature in the late 1990s, emerging from research on annexin
Anturein remains of academic interest as a model for studying anti-inflammatory pathways. Its research highlights the